Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin 71(3):209–49. https://doi.org/10.3322/caac.21660

Article  Google Scholar 

Hong R, Xu B (2022) Breast cancer: an up-to-date review and future perspectives. 42(10):913–36. https://doi.org/10.1002/cac2.12358

Pondé NF, Zardavas D, Piccart M (2018) Progress in adjuvant systemic therapy for breast cancer. Nat Rev Clin Oncol 16(1):27–44. https://doi.org/10.1038/s41571-018-0089-9

Article  CAS  Google Scholar 

Liang Y, Zhang H, Song X, Yang Q (2020) Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol 60:14–27. https://doi.org/10.1016/j.semcancer.2019.08.012

Article  CAS  PubMed  Google Scholar 

Yersal O, Barutca S (2014) Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol 5(3):412–24. https://doi.org/10.5306/wjco.v5.i3.412

Article  PubMed  PubMed Central  Google Scholar 

Zhou X, Li L, Guo X, Zhang C, Du Y, Li T et al (2022) HBXIP induces anoikis resistance by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis and stabilize Prdx1 in breast cancer. NPJ Breast Cancer 8(1):7. https://doi.org/10.1038/s41523-021-00374-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paoli P, Giannoni E, Chiarugi P (2013) Anoikis molecular pathways and its role in cancer progression. Biochimica et Biophysica Acta (BBA) - Mol Cell Res 1833(12):3481–98. https://doi.org/10.1016/j.bbamcr.2013.06.026

Article  CAS  Google Scholar 

Jang E-J, Sung JY, Yoo H-E, Jang H, Shim J, Oh E-S et al (2021) FAM188B downregulation sensitizes lung cancer cells to anoikis via EGF R downregulation and inhibits tumor metastasis in vivo. Cancers (Basel) 13(2):247. https://doi.org/10.3390/cancers13020247

Article  CAS  PubMed  Google Scholar 

Yu Y, Song Y, Cheng L, Chen L, Liu B, Lu D et al (2022) CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells. J Exp Clin Cancer Res 41(1):188. https://doi.org/10.1186/s13046-022-02381-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Fredericks T, Xiong G, Qi Y, Rychahou PG, Li J-D et al (2018) Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance. Breast Cancer Res 20(1):116. https://doi.org/10.1186/s13058-018-1030-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY, Gong W et al (2015) Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218–5p. Cell Death Dis 6(1):e1583. https://doi.org/10.1038/cddis.2014.541

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beermann J, Piccoli M-T, Viereck J, Thum T (2016) Non-coding RNAs in development and disease: background, mechanisms, an d therapeutic approaches. Physiol Rev 96(4):1297–325. https://doi.org/10.1152/physrev.00041.2015

Article  CAS  PubMed  Google Scholar 

Smolarz B, Zadrożna-Nowak A, Romanowicz H (2021) The role of lncRNA in the development of tumors, including breast cancer. Int J Mol Sci 22(16):8427. https://doi.org/10.3390/ijms22168427

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bin X, Hongjian Y, Xiping Z, Bo C, Shifeng Y, Binbin T (2018) Research progresses in roles of LncRNA and its relationships with breast cancer. Cancer Cell Int 18:179. https://doi.org/10.1186/s12935-018-0674-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y-Y, Li X-W, Li X-D, Zhou T-T, Chen C, Liu J-W et al (2022) Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy. Front Immunol 13:1055304. https://doi.org/10.3389/fimmu.2022.1055304

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li B, Chan HL, Chen P (2019) Immune checkpoint inhibitors: basics and challenges. Curr Med Chem 26(17):3009–25. https://doi.org/10.2174/0929867324666170804143706

Article  CAS  PubMed  Google Scholar 

Adeshakin FO, Adeshakin AO, Afolabi LO, Yan D, Zhang G, Wan X (2021) Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming. Front Oncol 11:626577. https://doi.org/10.3389/fonc.2021.626577

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan J-h, Yang F, Wang F, Ma J-z, Guo Y-j, Tao Q-f et al (2014) A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 25(5):666–81. https://doi.org/10.1016/j.ccr.2014.03.010

Article  CAS  PubMed  Google Scholar 

Lucere KM, O’Malley MMR, Diermeier SD (2020) Functional screening techniques to identify long non-coding RNAs as therapeutic targets in cancer. Cancers (Basel) 12(12):3695. https://doi.org/10.3390/cancers12123695

Article  CAS  PubMed  Google Scholar 

Baba SK, Baba SK, Mir R, Elfaki I, Algehainy N, Ullah MF et al (2023) Long non-coding RNAs modulate tumor microenvironment to promote metastasis: novel avenue for therapeutic intervention. Front Cell Dev Biol 11:1164301. https://doi.org/10.3389/fcell.2023.1164301

Article  PubMed  PubMed Central  Google Scholar 

Xiong Z, Ge Y, Xiao J, Wang Y, Li L, Ma S et al (2022) GAS1RR, an immune-related enhancer RNA, is related to biochemical recurrence-free survival in prostate cancer. Exp Biol Med (Maywood) 248(1):1–13. https://doi.org/10.1177/15353702221131888

Article  CAS  PubMed  Google Scholar 

Salimian N, Peymani M, Ghaedi K, Mirzaei S, Hashemi M (2023) Diagnostic and therapeutic potential of LINC01929 as an oncogenic LncR. Pathol Res Pract 244:154409. https://doi.org/10.1016/j.prp.2023.154409

Article  CAS  PubMed  Google Scholar 

Jiang T, Wang Y, Chen X, Xia W, Xue S, Gu L et al (2023) Neutrophil extracellular traps (NETs)-related lncRNAs signature for predicting prognosis and the immune microenvironment in breast cancer. Front Cell Dev Biol 11:1117637. https://doi.org/10.3389/fcell.2023.1117637

Article  PubMed  PubMed Central  Google Scholar 

Yao Z-Y, Xing C, Cai S, Xing X-L (2022) Development and validation of ferroptosis-related lncRNAs as prognosis and diagnosis biomarkers for breast cancer. Biomed Res Int 2022:2390764. https://doi.org/10.1155/2022/2390764

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou B, Guo H, Tang J (2019) Long Non-Coding RNA TFAP2A-AS1 Inhibits cell proliferation and invasion in breast cancer via miR-933/SMAD2. Med Sci Monit 25:1242–53. https://doi.org/10.12659/MSM.912421

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Ma L, Zhang T, Li P, Xu J, Wang Z (2021) Long noncoding RNA TFAP2A-AS1 exerts promotive effects in non-small cell lung cancer progression via controlling the microRNA-548a-3p/CDK4 axis as a competitive endogenous RNA. Oncol Res 29(2):129–39. https://doi.org/10.32604/or.2022.03563

Article  PubMed  Google Scholar 

Yang K, Niu Y, Cui Z, Jin L, Peng S, Dong Z (2022) Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression. Mol Carcinog 61(9):865–75. https://doi.org/10.1002/mc.23438

Article  CAS  PubMed  Google Scholar 

Tong H, Li T, Gao S, Yin H, Cao H, He W (2021) An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer. Biosci Rep 41(1):BSR20203944. https://doi.org/10.1042/BSR20203944

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pei X, Wang X, Li H (2018) LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448/IDO. Int J Biol Macromol 118(Pt A):24–30. https://doi.org/10.1016/j.ijbiomac.2018.06.033

Article  CAS  PubMed  Google Scholar 

Wei B, Kong W, Mou X, Wang S (2019) Comprehensive analysis of tumor immune infiltration associated with endogenous competitive RNA networks in lung adenocarcinoma. Pathol Res Pract 215(1):159–70. https://doi.org/10.1016/j.prp.2018.10.032

Article  CAS  PubMed  Google Scholar